Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Kohjin Bio Co., Ltd. (177A:JPX), powered by AI.
Kohjin Bio Co., Ltd. is currently trading at ¥1,019. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Kohjin Bio Co., Ltd. on Alpha Lenz.
Kohjin Bio Co., Ltd.'s P/E ratio is 6.2.
“Kohjin Bio Co., Ltd. trades at a P/E of 6.2 (undervalued) with strong ROE of 17.4%.”
Ask for details →Kohjin Bio Co., Ltd. operates as a company focused on the development, manufacturing, and distribution of biological and biochemical products. With its roots in innovation and scientific advancement, Kohjin Bio is renowned for producing high-quality nutritional supplements and health-related solutions. The company's primary function is to cater to the wellness and healthcare industry, offering products that support and enhance health through scientifically backed formulations. Notable features of Kohjin Bio's offerings include an emphasis on naturally derived ingredients and cutting-edge biotechnological processes. These products are critical to medical and health sectors, impacting areas such as dietary supplementation and preventive healthcare. As a significant player in the life sciences market, Kohjin Bio Co., Ltd. contributes to the well-being of populations by delivering trusted and effective health products, standing as a reputable entity in both domestic and international markets. Its role is crucial in driving innovations that meet the growing demand for health-conscious living solutions.
“Kohjin Bio Co., Ltd. trades at a P/E of 6.2 (undervalued) with strong ROE of 17.4%.”
Ask for details →Kohjin Bio Co., Ltd. (ticker: 177A) is a company listed on JPX in the Healthcare sector (Biotechnology). It has approximately 167 employees. Market cap is $5.0B.
The current price is 1,019 with a P/E ratio of 6.25x and P/B of 0.86x.
ROE is 17.42% and operating margin is 19.04%. Annual revenue is $5.2B.